ahlam1399
03-15-2016, 06:27 PM
Teva Pharm sees close of $40.5 bln Allergan generics deal by June
TEL AVIV, March 15 (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday it **w expects its $40.5 billion acquisition of the generic drug activities of Allergan to be completed by...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=NvJ_VAHmXzw:-JACkD4RAE0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=NvJ_VAHmXzw:-JACkD4RAE0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=NvJ_VAHmXzw:-JACkD4RAE0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=NvJ_VAHmXzw:-JACkD4RAE0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=NvJ_VAHmXzw:-JACkD4RAE0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/NvJ_VAHmXzw
TEL AVIV, March 15 (Reuters) - Israel-based Teva Pharmaceutical Industries said on Tuesday it **w expects its $40.5 billion acquisition of the generic drug activities of Allergan to be completed by...http://feeds.feedburner.com/~ff/reuters/mergersNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/mergersNews?a=NvJ_VAHmXzw:-JACkD4RAE0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=NvJ_VAHmXzw:-JACkD4RAE0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/mergersNews?a=NvJ_VAHmXzw:-JACkD4RAE0:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/mergersNews?i=NvJ_VAHmXzw:-JACkD4RAE0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/mergersNews?a=NvJ_VAHmXzw:-JACkD4RAE0:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/mergersNews/~4/NvJ_VAHmXzw